Immunoglobulin Nephropathy
📧 Sign up to get email alerts when something new happens for Immunoglobulin Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Update: Atrasentan in Patients With IgA Nephropathy [Phase 3]
Phase 3 trial update for atrasentan in IgA nephropathy is active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN) [Phase 3]
Phase 3 trial of sibeprenlimab in immunoglobulin A nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Results: Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy [Phase 2]
Phase 2 trial assessing efficacy and safety of Felzartamab (MOR202), a human anti-CD38 antibody, in IgA nephropathy; study completed with re…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) [Phase 2]
A Phase 2 study of ravulizumab in proliferative lupus nephritis and immunoglobulin A nephropathy has been terminated, with results posted in…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN) [Phase 3]
Phase 3 clinical trial evaluating the efficacy of povetacicept in adults with Immunoglobulin A nephropathy; the study is currently active bu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN [Phase 2]
A Phase 2 study evaluating the safety and effectiveness of sparsentan in combination with an SGLT2 inhibitor in immunoglobulin A nephropathy…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: First in Human Study to Assess Safety of VIS649 in Healthy Subjects [Phase 1]
First-in-human Phase 1 study to assess the safety of VIS649 in healthy subjects has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Safety and Efficacy Study of VIS649 for IgA Nephropathy [Phase 2]
Phase 2 safety and efficacy study of VIS649 for Immunoglobulin A nephropathy has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Efficacy and Safety in Chinese Patients with Immunoglobulin a Nephropathy (IgAN) Who Have Completed Study Nef-301 [Phase 3]
Phase 3 trial Nef-301 evaluating efficacy and safety in Chinese patients with Immunoglobulin A nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN) [Phase 2]
Phase 2 study evaluating safety and tolerability of BCX9930 in complement-mediated kidney diseases was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade [Phase 2]
Open-label Phase 2 study to evaluate safety and efficacy of CCX168 in subjects with immunoglobulin A nephropathy on stable RAAS blockade; st…
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1 [Phase 3]
This clinical trial update reports the start of Phase 3 evaluation for a treatment targeting Immunoglobulin A nephropathy (IgA nephropathy) …
-
CLINICAL_TRIALS trial_result · 2011-09-16Clinical Trial Update: Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy [Phase 2]
A Phase 2 trial assessed sirolimus for poor prognosis Immunoglobulin A nephropathy; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: Calcitriol in the Treatment of Immunoglobulin A Nephropathy [Phase 4]
Phase 4 study of calcitriol for immunoglobulin A nephropathy is reported, with the trial status currently UNKNOWN. Sponsor: Peking Universit…